基于增强非DCE MRI的O-RADS MRI风险分层系统在附件肿块评估中的准确性与可重复性
本研究纳入308例患者共362个附件肿块,由三位阅片者按O-RADS MRI系统评分,以病理为参考标准。O-RADS MRI评分≥4预测恶性的AUC为0.882-0.918,敏感度83.3%-90.5%,特异度93.1%-95.3%,观察者内和观察者间一致性极好(k=0.883和0.848)。结论认为基于增强非DCE MRI的O-RADS MRI系统具有高准确性和可重复性。
要点
- O-RADS MRI评分≥4预测附件肿块恶性具有高准确性和可重复性。
- 评分1-2的病灶中未见恶性肿瘤,支持其良性归类。
- 增强非DCE MRI可作为无法行DCE时的替代诊断工具。
核心结论
- 基于增强非DCE MRI的O-RADS MRI风险分层系统在预测附件肿块恶性方面表现出高准确性和可重复性。
- 增强非DCE MRI可作为无法进行DCE时的替代诊断工具。
研究设计与样本
- 单中心回顾性研究?原文未明确研究类型,纳入术前一个月内行常规盆腔增强非DCE MRI检查的患者。
- 共纳入308例患者(平均年龄42.09±12.42岁,范围20-84岁),362个附件肿块(320个良性,42个恶性)。
- 由两位经验丰富的放射科医生独立评估并评分,其中一位三个月后重新评分;以组织学为参考标准。
诊断标准与关键数值
- O-RADS MRI评分1-3分为良性,4-5分为恶性;三位阅片者中评分1-2的病灶均无恶性。
- O-RADS MRI评分≥4预测恶性的AUC分别为0.918(95%CI 0.864-0.972)、0.905(95%CI 0.842-0.968)、0.882(95%CI 0.815-0.950)。
- 敏感度分别为90.5%(95%CI 87.5-93.5%)、85.7%(95%CI 82.1-89.3%)、83.3%(95%CI 79.5-87.2%)。
- 特异度分别为93.1%(95%CI 90.5-95.7%)、95.3%(95%CI 93.1-97.5%)、93.1%(95%CI 90.5-95.7%)。
- 观察者内一致性k=0.883(95%CI 0.814-0.952),观察者间一致性k=0.848(95%CI 0.770-0.926)。
临床应用与阅片要点
- 在日常阅片中可依据O-RADS MRI评分≥4提示恶性风险高,评分1-2可归为良性。
- 增强非DCE MRI序列可用于无法进行DCE检查的患者,评分系统仍保持高诊断效能。
- 注意评分系统的观察者间一致性高,但需由经验丰富的放射科医生评估。
局限性
- 单中心研究,样本量有限(308例患者),可能存在选择偏倚。
- 回顾性设计,未与DCE MRI直接比较诊断效能。
- 原文未报告阅片者经验对评分的具体影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Evaluation of the diagnostic performance and reproducibility of the Ovarian-Adnexal Reporting and Data System (O-RADS) Magnetic Resonance Imaging (MRI) risk stratification system based on enhanced non-dynamic contrast-enhanced (non-DCE) MRI in the diagnosis of adnexal masses.
METHODS: Patients who underwent conventional pelvic enhanced non-DCE MRI examination within one month prior to surgery formed the study population. Two experienced radiologists independently evaluated the images and assigned a score according to the O-RADS MRI risk stratification system. One of the radiologists reviewed the images and reassigned the scores after three months. Intra- and inter-observer agreement was evaluated with the k coefficient value. The adnexal masses that attained scores between 1 and 3 were considered benign, while those with scores of 4 or 5 were considered malignant. Analyses were conducted to determine the sensitivity, specificity, positive and negative predictive values, and receiver operating characteristic (ROC) curve, which were then used for evaluating the diagnostic efficacy of the developed system based on enhanced non-DCE MRI scan. The reference standard was histology.
RESULTS: A total of 308 patients (mean age: 42.09 ± 12.42 years, age range: 20-84 years) were enrolled in the study. Among the 362 adnexal masses from the included patients, there were 320 benign masses and 42 malignant masses. In the case of three readers, there were no malignant tumors scored 1-2. The O-RADS MRI score ≥ 4 was associated with malignancy resulted in a good diagnostic efficacy with the areas under the curve (AUC) values of 0.918 (95 % CI, 0.864-0.972), 0.905 (95 % CI, 0.842-0.968), and 0.882 (95 % CI, 0.815-0.950), the sensitivity values of 90.5 % (95 % CI, 87.5-93.5 %), 85.7 % (95 % CI, 82.1-89.3 %), and 83.3 % (95 % CI, 79.5-87.2 %), and the specificity values of 93.1 % (95 % CI, 90.5-95.7 %), 95.3 % (95 % CI, 93.1-97.5 %), and 93.1 % (95 % CI, 90.5-95.7 %) obtained for the three readers, respectively. Excellent intra-observer agreement and inter-observer agreement were observed with the k values of 0.883 (95 % CI, 0.814-0.952) and 0.848 (95 % CI, 0.770-0.926), respectively.
CONCLUSIONS: The O-RADS MRI risk stratification system based on enhanced non-DCE MRI scans exhibited high accuracy and reproducibility in the prediction of adnexal masses malignancy. Enhanced non-DCE MRI scan may offer an alternative diagnostic tool when DCE is not possible.
引用
- Wu, Tang, Cai, et al. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses. Eur J Radiol. 2022. PMID: 36584564. doi:10.1016/j.ejrad.2022.110670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。